As of 2024-12-15, the Relative Valuation of Cellectis SA (ALCLS.PA) is (14.61) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 1.67 EUR, the upside of Cellectis SA based on Relative Valuation is -975.8%.
The range of the Relative Valuation is (13.74) - (17.50) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 15.4x | 14.6x |
| Forward P/E multiples | 6.2x - 13.5x | 7.9x |
| Fair Price | (13.74) - (17.50) | (14.61) |
| Upside | -923.6% - -1149.4% | -975.8% |
| Date | P/E |
| 2024-12-13 | -1.22 |
| 2024-12-12 | -1.30 |
| 2024-12-11 | -1.35 |
| 2024-12-10 | -1.36 |
| 2024-12-09 | -1.35 |
| 2024-12-06 | -1.33 |
| 2024-12-05 | -1.30 |
| 2024-12-04 | -1.32 |
| 2024-12-03 | -1.32 |
| 2024-12-02 | -1.37 |
| 2024-11-29 | -1.42 |
| 2024-11-28 | -1.37 |
| 2024-11-27 | -1.42 |
| 2024-11-26 | -1.40 |
| 2024-11-25 | -1.29 |
| 2024-11-22 | -1.27 |
| 2024-11-21 | -1.25 |
| 2024-11-20 | -1.27 |
| 2024-11-19 | -1.31 |
| 2024-11-18 | -1.27 |
| 2024-11-15 | -1.27 |
| 2024-11-14 | -1.29 |
| 2024-11-13 | -1.32 |
| 2024-11-12 | -1.28 |
| 2024-11-11 | -1.24 |
| 2024-11-08 | -1.25 |
| 2024-11-07 | -1.24 |
| 2024-11-06 | -1.25 |
| 2024-11-05 | -1.25 |
| 2024-11-04 | -1.27 |
| 2024-11-01 | -1.24 |
| 2024-10-31 | -1.26 |
| 2024-10-30 | -1.25 |
| 2024-10-29 | -1.28 |
| 2024-10-28 | -1.28 |
| 2024-10-25 | -1.28 |
| 2024-10-24 | -1.30 |
| 2024-10-23 | -1.28 |
| 2024-10-22 | -1.30 |
| 2024-10-21 | -1.32 |
| 2024-10-18 | -1.35 |
| 2024-10-17 | -1.34 |
| 2024-10-16 | -1.34 |
| 2024-10-15 | -1.34 |
| 2024-10-14 | -1.34 |
| 2024-10-11 | -1.37 |
| 2024-10-10 | -1.37 |
| 2024-10-09 | -1.41 |
| 2024-10-08 | -1.36 |
| 2024-10-07 | -1.33 |